Use case
Regulatory affairs and quality teams at AI diagnostic and software medical device makers, after model training and before market launch or a minor update, compile model documentation, clinical and quality materials, submit them to a notified body and obtain a conformity assessment outcome and certificate.
Makers submit to general-purpose notified bodies among the roughly 52 designated under the EU Medical Device Regulation and queue through a general review process.
Public material states an AI diagnostic model can be trained in weeks, yet expert assessment takes 12 to 18 months, with another six to eight months for a minor update, so iteration is gated by review throughput.
xOcto's call
Demand is evidenced
Trend: AI medical device iteration now outpaces traditional certification review, making regulatory designation itself a scarce supply. Entry point: start with AI diagnostics, imaging and software device makers that ship frequent minor updates, turning change approval into a predictable service; also watch compliance support for Chinese and Southeast Asian makers entering the EU and US.
Reason to use it
Why users would choose it
Inference: versus queuing at general notified bodies, Scarlet focuses solely on software and AI and says its process is built for iterative development, potentially shortening the most painful change-approval wait, so AI diagnostics and software device makers shipping frequent minor updates would choose it at launch and update points; no public comparison of actual review times is given, so this is inference.
Where the easy answer breaks down
The tension worth following
An English validation note will follow from the public evidence.
If this is your job
Worth trying. Inference: versus queuing at general notified bodies, Scarlet focuses solely on software and AI and says its process is built for iterative development, potentially shortening the most painful change-approval wait, so AI diagnostics and software device makers shipping frequent minor updates would choose it at launch and update points; no public comparison of actual review times is given, so this is inference.
Entry and what to borrow
Trend: AI medical device iteration now outpaces traditional certification review, making regulatory designation itself a scarce supply. Entry point: start with AI diagnostics, imaging and software device makers that ship frequent minor updates, turning change approval into a predictable service; also watch compliance support for Chinese and Southeast Asian makers entering the EU and US.